Role of cox-2 mediated neuroinflammation on the neurodegeneration and cognitive impairments in colchicine induced rat model of Alzheimer's Disease
- 1 February 2016
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 291, 115-124
Abstract
No abstract availableKeywords
Funding Information
- University Grant Commission — Major Research Project (42-532/2013)
This publication has 29 references indexed in Scilit:
- Nootropic activity of acetaminophen against colchicine induced cognitive impairment in ratsJournal of Clinical Biochemistry and Nutrition, 2012
- Preoperative administration of etoricoxib in patients undergoing hip replacement causes inhibition of inflammatory mediators and pain reliefEuropean journal of pain, 2011
- Endocannabinergic Modulation of Interleukin-1β in Mouse Hippocampus under Basal Conditions and after in vivo Systemic Lipopolysaccharide StimulationNeuroimmunomodulation, 2011
- Molecular Basis for Cyclooxygenase Inhibition by the Non-steroidal Anti-inflammatory Drug NaproxenJournal of Biological Chemistry, 2010
- Peripheral origin of IL-1β production in the rodent hippocampus under in vivo systemic bacterial lipopolysaccharide (LPS) challenge and its regulation by P2X7 receptorsJournal of Neuroimmunology, 2009
- Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Microglia: Intrinsic immuneffector cell of the brainBrain Research Reviews, 1995
- Microtubule disruption and cognitive defects: Effect of colchicine on learning behavior in ratsPharmacology Biochemistry and Behavior, 1991
- Cholinergic cell loss and cognitive impairments following intraventricular or intradentate injection of colchicineBrain Research, 1990
- Prostaglandins and the central nervous systemPostgraduate Medical Journal, 1977